DBS Group Research

Broker's Calls

DBS maintains ‘fully valued’ on Sarine Technologies at reduced target price amid dimmer outlook

DBS analysts think it is premature to conclude that diamond markets are recovering, but continue to watch for signs of recovery.

Broker's Calls

DBS upgrades Frencken to ‘buy’ with higher TP of $1.33

The group’s revenue and patmi have been improving sequentially from the 1QFY2023 to 3QFY2023.

Broker's Calls

Silverlake Axis boasts robust pipeline

Silverlake Axis 1QFY2024 earnings of RM48.9 million ($14.4 million) are its highest when compared to the three previous quarters.
DBS lowers ThaiBev’s TP to 75 cents, says valuation is ‘unjustifiably low’ - THE EDGE SINGAPORE

Broker's Calls

DBS believes ThaiBev's valuation is ‘unjustifiably low’; trims target price on higher equity risk premium

The analysts are recommending investors to load up in the company’s shares before its price increases.

Broker's Calls

Brokers’ Digest: StarHub, Nanofilm, ST Engineering, FHT, Sats

See what the analysts have to say this week.
Analysts keep estimates unchanged for OCBC; bank named as top sector pick for some - THE EDGE SINGAPORE

Broker's Calls

Analysts keep estimates unchanged for OCBC; bank named as top sector pick for some

Analysts' target prices range from $12.97 to $14.96.

Broker's Calls

Brokers' Digest: Japfa, HRnetGroup, Keppel Infrastructure Trust, Frencken

See what the analysts have to say this week.

Broker's Calls

Analysts keep 'buy', 'add' and 'accumulate' calls on Sembcorp after $14 bil renewable energy solution plan announced

Sembcorp will fund these initiatives without equity fundraising, but analysts believe in its strong operating cash flow.

Broker's Calls

Analysts maintain 'buy' on Frasers Hospitality Trust on the back of strong event pipeline and recovery tailwinds

FHT’s corporate-positioned hotels in Singapore will continue to see further traction from the return of corporate travel.
Analysts downgrade, trim TP on Raffles Medical after 'margins collapsed' in 3QFY2023 - THE EDGE SINGAPORE

Broker's Calls

Analysts downgrade, trim TP on Raffles Medical after 'margins collapsed' in 3QFY2023

Raffles Medical Group posted profit after tax of $12.4 million for the 3QFY2023 ended Sept 30, 67.4% lower y-o-y.
×